[Federal Register Volume 80, Number 54 (Friday, March 20, 2015)]
[Rules and Regulations]
[Pages 14838-14839]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-06425]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 14
[Docket No. FDA-2012-N-0218]
Advisory Committee; Antiviral Drugs Advisory Committee;
Termination
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing the
termination of the Antiviral Drugs Advisory Committee. This document
removes the Antiviral Drugs Advisory Committee from the Agency's list
of standing advisory committees.
DATES: This rule is effective March 20, 2015.
[[Page 14839]]
FOR FURTHER INFORMATION CONTACT: Michael Ortwerth, Advisory Committee
Oversight and Management Staff, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 32, Rm. 5129, Silver Spring, MD 20993-0002, 301-
796-8220, FAX: 301-847-8640, or [email protected].
SUPPLEMENTARY INFORMATION: The Antiviral Drugs Advisory Committee was
established on October 7, 1980 (see 45 FR 79025, November 28, 1980).
The Committee reviews and evaluates available data concerning the
safety and effectiveness of marketed and investigational human drug
products for use in the treatment of acquired immune deficiency
syndrome, human immunodeficiency virus related illnesses, and other
viral, fungal and mycobacterial infections. The Committee is no longer
needed and was terminated on February 15, 2015.
Under 5 U.S.C. 553(b)(3)(B) and (d) and 21 CFR 10.40(d) and (e),
the Agency finds good cause to dispense with notice and public comment
procedures and to proceed to an immediate effective date on this rule.
Notice and public comment and a delayed effective date are unnecessary
and are not in the public interest as this final rule merely removes
the name of the Antiviral Drugs Advisory Committee from the list of
standing advisory committees in Sec. 14.100 (21 CFR 14.100).
Therefore, the Agency is amending Sec. 14.100(c) as set forth in
the regulatory text of this document.
List of Subjects in 21 CFR Part 14
Administrative practice and procedure, Advisory committees, Color
additives, Drugs, Radiation protection.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs, 21 CFR part
14 is amended as follows:
PART 14--PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE
0
1. The authority citation for 21 CFR part 14 continues to read as
follows:
Authority: 5 U.S.C. App. 2; 15 U.S.C. 1451-1461, 21 U.S.C. 41-
50, 141-149, 321-394, 467f, 679, 821, 1034; 28 U.S.C. 2112; 42
U.S.C. 201, 262, 263b, 264; Pub. L. 107-109; Pub. L. 108-155; Pub.
L. 113-54.
Sec. 14.100 [Amended]
0
2. Section 14.100 is amended by removing paragraph (c)(3) and
redesignating paragraphs (c)(4) through (18) as paragraphs (c)(3)
through (17).
Dated: March 16, 2015.
Jill Hartzler Warner,
Associate Commissioner for Special Medical Programs.
[FR Doc. 2015-06425 Filed 3-19-15; 8:45 am]
BILLING CODE 4164-01-P